Exclusive

Publication

Byline

SystImmune, Biokin Secure First China Approval for Bispecific ADC Iza-bren

Singapore, June 23 -- SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, also known as BL-B01D1, for the treatment of recurrent or met... Read More


Sankara Eye Hospital and Chinese University of Hong Kong ink MoU to revolutionise paediatric eye care and myopia treatment

Singapore, June 23 -- Sankara Eye Hospital, India and The Chinese University of Hong Kong (CUHK) recently signed a landmark Memorandum of Understanding (MoU) to revolutionise paediatric eye care and m... Read More


Sisram Medical bolsters Energy-Based Devices and injectables in Thailand

Singapore, June 23 -- Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has officially rolled out its Soprano Titanium across... Read More


Abu Dhabi's government partners with Sanofi to advance vaccine innovation

Singapore, June 23 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum ... Read More


China's CARsgen announces approval of Satri-cel, world's first CAR T-cell therapy product for solid tumours

Singapore, June 23 -- China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as informed by the National Medical Products Administration ... Read More


Murj(R) expands global footprint with commercial launch in Australia and NZ

Singapore, June 22 -- Murj(R), a US-based cardiac device management software company, has announced its official expansion into the Australian market alongside broader availability for New Zealand (NZ... Read More


Chime Biologics deepens collaboration with Cytiva to boost manufacturing capacity in China

Singapore, June 22 -- Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inauguration of its GMP-2 manufacturing facility in Wuhan, China... Read More


Korea's SK Biopharma collaborates with Insilico Medicine for $2.5 B AI-drug discovery deal

Singapore, June 22 -- Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and South Korea-based SK Biopharmaceuticals, have annou... Read More


Indo-NZ researchers explore DNA-based approach to improve prostate cancer detection

Singapore, June 22 -- Researchers at the University of Otago, New Zealand are investigating a blood-based prostate cancer detection approach using DNA methylation biomarkers. DNA methylation, a biolog... Read More


Shimadzu Corporation releases PPSQ-51A/53A SPD-40 model protein sequencers

Singapore, June 22 -- Japan-based Shimadzu Corporation has released the PPSQ-51A/53A SPD-40 model protein sequencers. These instruments can be used to analyse the amino acid sequences in proteins, suc... Read More